Scarica l'app Stockscreener
5.245
1.06%
0.055
Precedente Chiudi:
$5.19
Aprire:
$5.16
Volume 24 ore:
376.25K
Relative Volume:
0.71
Capitalizzazione di mercato:
$264.30M
Reddito:
$230.47M
Utile/perdita netta:
$30.28M
Rapporto P/E:
8.5984
EPS:
0.61
Flusso di cassa netto:
$38.86M
1 W Prestazione:
+3.86%
1M Prestazione:
+7.04%
6M Prestazione:
+47.33%
1 anno Prestazione:
+65.98%
Intervallo 1D:
$5.16
$5.315
Intervallo di 1 settimana:
$4.835
$5.315
Portata 52W:
$2.575
$6.12
Puma Biotechnology Inc Stock (PBYI) Company Profile
Nome
Puma Biotechnology Inc
Settore
Industria
Telefono
(424) 248-6500
Indirizzo
10880 WILSHIRE BLVD., LOS ANGELES, CA
Confronta PBYI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
5.245 | 261.53M | 230.47M | 30.28M | 38.86M | 0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-09-28 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-06-25 | Ripresa | BofA/Merrill | Underperform |
| 2019-10-08 | Downgrade | Goldman | Neutral → Sell |
| 2019-05-10 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-10 | Downgrade | Citigroup | Buy → Neutral |
| 2019-01-17 | Iniziato | Leerink Partners | Mkt Perform |
| 2019-01-03 | Downgrade | Guggenheim | Buy → Neutral |
| 2018-11-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-11-02 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2018-11-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-10-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-09-17 | Iniziato | Goldman | Sell |
| 2018-05-11 | Reiterato | Stifel | Buy |
| 2017-11-10 | Reiterato | Citigroup | Buy |
| 2017-11-10 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-02 | Reiterato | Stifel | Buy |
| 2017-09-11 | Reiterato | Credit Suisse | Outperform |
| 2017-07-10 | Ripresa | Leerink Partners | Outperform |
| 2017-06-06 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-05-25 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-03-02 | Reiterato | RBC Capital Mkts | Sector Perform |
Mostra tutto
Puma Biotechnology Inc Borsa (PBYI) Ultime notizie
What insider trading reveals about Puma Biotechnology Inc. stock2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
With 60% ownership of the shares, Puma Biotechnology, Inc. (NASDAQ:PBYI) is heavily dominated by institutional owners - Yahoo Finance
Puma Biotechnology, Inc. (PBYI) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
What dividend safety score for Puma Biotechnology Inc. stockPortfolio Growth Summary & Precise Buy Zone Tips - moha.gov.vn
Total debt per share of Puma Biotechnology, Inc. – TRADEGATE:0PB - TradingView
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick? - sharewise.com
Check out these key findings about Puma Biotechnology Inc (PBYI) - Setenews
Will Puma Biotechnology Inc. stock continue upward momentumGDP Growth & AI Forecast Swing Trade Picks - newser.com
Is Puma Biotechnology Inc. stock affected by interest rate hikes2025 Earnings Impact & Real-Time Volume Surge Alerts - newser.com
Using Ichimoku Cloud for Puma Biotechnology Inc. technicalsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
Using data filters to optimize entry into Puma Biotechnology Inc.July 2025 Drop Watch & Intraday High Probability Alerts - newser.com
Published on: 2025-11-19 05:37:08 - newser.com
Using fundamentals and technicals on Puma Biotechnology Inc.Trend Reversal & Stepwise Trade Execution Plans - newser.com
Adversity is less terrifying than hope: Puma Biotechnology Inc (PBYI) - Setenews
1stdibs.Com And 2 Other Penny Stocks To Watch Closely - simplywall.st
Puma Biotechnology, Inc.Corporate Presentation, November 2025 (11/17/2025 10: 08 - MarketScreener
How strong is Puma Biotechnology Inc. stock revenue growthWeekly Trade Review & Capital Protection Trading Alerts - newser.com
Using R and stats models for Puma Biotechnology Inc. forecastingJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - newser.com
Published on: 2025-11-18 22:41:28 - newser.com
Published on: 2025-11-14 15:23:18 - newser.com
Can Puma Biotechnology Inc. stock withstand economic slowdownMarket Activity Summary & Entry Point Strategy Guides - newser.com
Why retail investors favor Puma Biotechnology Inc. stock2025 Growth vs Value & Weekly Breakout Watchlists - Fundação Cultural do Pará
Aug Final Week: Is Puma Biotechnology Inc. stock a safe buy before earnings - Fundação Cultural do Pará
Insider Sell: Michael Miller Sells 20,000 Shares of Puma Biotech - GuruFocus
Puma Biotechnology Director Sells 20,000 Shares - TradingView
[Form 4] PUMA BIOTECHNOLOGY, INC. Insider Trading Activity - Stock Titan
Puma Biotechnology Inc Azioni (PBYI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):